CD44 and urinary bladder carcinoma: Serial chemotherapy can promote the enrichment of CSCs and tumor repopulation via COX‐2/PGE2 signaling in bladder cancer 10, and PGE2 can increase CD44+ and CD133+ CSCs subpopulation‐mediated EP4 signaling in colon cancer 36.